Skip to main content
Article
Neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreas adenocarcinoma: influence of vascular margin status and type of chemotherapy
HPB
  • Michael Chuong, Baptist Health Medical Group; Miami Cancer Institute
Publication Date
5-1-2023
Content Type
application/pdf
Publisher's Site:
View at Publisher Website
Additional Authors:

Additional authors and institutional affiliations

Citation Information

Palm, R. F., Boyer, E., Kim, D. W., Denbo, J., Hodul, P. J., Malafa, M., Fleming, J. B., Shridhar, R., Chuong, M. D., Mellon, E. A., Frakes, J. M., & Hoffe, S. E. (2023, 2023/09/01/). Neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreas adenocarcinoma: influence of vascular margin status and type of chemotherapy. HPB, 25(9), 1110-1120. https://doi.org/https://doi.org/10.1016/j.hpb.2023.04.019